Call for Papers  

Article Details

Adipose Tissue-Mesenchymal Stem Cells Caused to Change the Methylation Status of <i>hTERT</i> Gene Promoter CpG Islands of Molt-4 Leukemia Cells as Cell-based Therapy

[ Vol. 23 , Issue. 3 ]


Ezzatollah Fathi*, Soheila Montazersaheb, Somayeh Vandghanooni, Raheleh Farahzadi and Ilja Vietor   Pages 266 - 274 ( 9 )


<p>Background: DNA methylation was considered as prognostic information in some hematological malignancies. Previous studies have reported the in vitro and in vivo biology role of mesenchymal stem cells (MSCs) on leukemic cells. The aim of this study was to investigate the effect of MSCs on the promoter methylation status of hTERT as a catalytic subunit of telomerase enzyme. <p> Methods: In the experimental study, the Molt-4 leukemic cells were co-cultured with MSCs for 7 days. At the end of the co-culture period, the Molt-4 cells were collected, DNA and protein were extracted. Then methylation specific-PCR and western blotting were done for evaluating the hTERT gene promoter methylation status and cyclin D1 and hTERT protein expression, respectively. In the following, the flow cytometry was done for cell cycle distribution assay. <p> Results: It was found that MSCs resulted in a significant decrease in the cyclin D1 and hTERT protein expression levels. Also, MSCs caused changes in the methylation status of the CpG islands in the hTERT gene promoter region. The following results showed that MSCs caused a significant increase in the number of cells at G0/G1 phase and arrest the G0/G1 phase as well as decrease in the cell proliferation of Molt-4 cells. <p> Conclusion: It is concluded that co-culture of MSCs with Molt-4 cells could be involved in changing the methylation status of hTERT gene promoter, cell cycle and hTERT protein expression; it could be potentially beneficial for further investigations regarding the cell transplantation and cell-based therapy.</p>


Mesenchymal stem cells, hTERT gene promoter methylation status, Cell cycle distribution, Cyclin D1, Cell-based therapy, Telomerase.


Read Full-Text article